Shawn Kwatra, MD, FAAD, physician scientist at the University of Maryland Medical System, presented data at the American Academy of Dermatology 2025 annual conference on the rapid efficacy of topical ...
Late-stage data also showed that Johnson & Johnson’s icotrokinra was superior to Bristol Myers Squibb’s Sotyktu at clearing ...
The reduction in itch was the greatest contributor to quality-of-life improvement for adolescents and adults with atopic ...
Amgen’s $400 million eczema drug candidate has recorded two more phase 3 victories. The data drops provide more evidence that ...
Half of patients who used delgocitinib cream for chronic hand eczema had a profound response, and a third who stopped ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback